Subbu Nambi
Stock Analyst at Guggenheim
(3.72)
# 803
Out of 4,989 analysts
44
Total ratings
54.29%
Success rate
9.11%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $56 → $67 | $57.67 | +16.18% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $30.44 | +18.27% | 2 | Aug 13, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $185.91 | +34.47% | 2 | Jul 23, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $88 → $115 | $114.22 | +0.68% | 1 | Jun 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $65 → $75 | $79.23 | -5.34% | 3 | Jun 30, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $5.42 | +84.50% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $94.41 | +20.75% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $27.02 | +85.05% | 2 | May 6, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $9.56 | +4.60% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $53.12 | +12.95% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.72 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $32.68 | +13.22% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $32.01 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $163.91 | +22.02% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $46.58 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.78 | +58.73% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.72 | +733.22% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.06 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $124.51 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.70 | +10.13% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.25 | - | 1 | Dec 14, 2023 |
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $57.67
Upside: +16.18%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $30.44
Upside: +18.27%
Danaher
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $185.91
Upside: +34.47%
GeneDx Holdings
Jun 30, 2025
Maintains: Buy
Price Target: $88 → $115
Current: $114.22
Upside: +0.68%
Tempus AI
Jun 30, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $79.23
Upside: -5.34%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.42
Upside: +84.50%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $94.41
Upside: +20.75%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $27.02
Upside: +85.05%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.56
Upside: +4.60%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $53.12
Upside: +12.95%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.72
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $32.68
Upside: +13.22%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $32.01
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $163.91
Upside: +22.02%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $46.58
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.78
Upside: +58.73%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.72
Upside: +733.22%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $12.06
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $124.51
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $22.70
Upside: +10.13%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.25
Upside: -